Stay updated on Venetoclax and Navitoclax in ALL Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Navitoclax in ALL Clinical Trial page.

Latest updates to the Venetoclax and Navitoclax in ALL Clinical Trial page
- Check3 days agoChange DetectedThe page history shows an addition of revision v3.3.4 and removal of revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.3.3 is added; references to HHS Vulnerability Disclosure and Revision: v3.3.2 are removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the government funding lapse notice from the page; this minor change does not affect study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check74 days agoChange DetectedNew versions (e.g., 19, 20, and 21) with updated submission dates and statuses have been added to the Record History. These updates document ongoing QC reviews and changes to study status.SummaryDifference0.1%

- Check103 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference11%

Stay in the know with updates to Venetoclax and Navitoclax in ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Navitoclax in ALL Clinical Trial page.